MedTrace Logo

Sarah Cannon Outcomes Registry

NCT02356822 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-12-05

No results posted yet for this study

Summary

This is an investigational multi-site outcomes registry intended to collect information about a patient's cancer care. Patients may enter the Registry at any time during the patient's current stage in the continuum of care. The registries main objectives will be to measure and evaluate the effects of patient care throughout the care continuum, resulting in the identification of the most effective treatment options. Objectives will encompass evaluations and analytics around safety, effectiveness, and improved efficiencies.

Conditions

Interventions

OTHER

Patient registry

Oncology data registry

Sponsors & Collaborators

  • SCRI Development Innovations, LLC

    lead OTHER

Principal Investigators

  • Richard Geer, MD · Sarah Cannon

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2019-12-31
Completion
2024-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02356822 on ClinicalTrials.gov